Literature DB >> 20879029

Patatin-like phospholipase domain-containing 3 and the pathogenesis and progression of pediatric nonalcoholic fatty liver disease.

Jeffrey D Browning, Jonathan C Cohen, Helen H Hobbs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20879029      PMCID： PMC3135009          DOI： 10.1002/hep.23946

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  20 in total

1.  I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.

Authors:  Luca Valenti; Anna Alisi; Enrico Galmozzi; Andrea Bartuli; Benedetta Del Menico; Arianna Alterio; Paola Dongiovanni; Silvia Fargion; Valerio Nobili
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

2.  Histopathology of pediatric nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Cynthia Behling; Robert Newbury; Reena Deutsch; Caroline Nievergelt; Nicholas J Schork; Joel E Lavine
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

3.  Prevalence of fatty liver in children and adolescents.

Authors:  Jeffrey B Schwimmer; Reena Deutsch; Tanaz Kahen; Joel E Lavine; Christina Stanley; Cynthia Behling
Journal:  Pediatrics       Date:  2006-10       Impact factor: 7.124

4.  Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

Authors:  Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

5.  Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase.

Authors:  Robert Zimmermann; Juliane G Strauss; Guenter Haemmerle; Gabriele Schoiswohl; Ruth Birner-Gruenberger; Monika Riederer; Achim Lass; Georg Neuberger; Frank Eisenhaber; Albin Hermetter; Rudolf Zechner
Journal:  Science       Date:  2004-11-19       Impact factor: 47.728

6.  Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.

Authors:  Pouneh Mofrad; Melissa J Contos; Mahmadul Haque; Carol Sargeant; Robert A Fisher; Velimir A Luketic; Richard K Sterling; Mitchell L Shiffman; Richard T Stravitz; Arun J Sanyal
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

7.  Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities.

Authors:  Christopher M Jenkins; David J Mancuso; Wei Yan; Harold F Sims; Beverly Gibson; Richard W Gross
Journal:  J Biol Chem       Date:  2004-09-10       Impact factor: 5.157

8.  Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease.

Authors:  Naga Chalasani; Laura Wilson; David E Kleiner; Oscar W Cummings; Elizabeth M Brunt; Aynur Unalp
Journal:  J Hepatol       Date:  2008-02-12       Impact factor: 25.083

9.  Ethnic differences in the prevalence of cryptogenic cirrhosis.

Authors:  Jeffrey D Browning; K Shiva Kumar; M Hossein Saboorian; Dwain L Thiele
Journal:  Am J Gastroenterol       Date:  2004-02       Impact factor: 10.864

10.  Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.

Authors:  Xin Yuan; Dawn Waterworth; John R B Perry; Noha Lim; Kijoung Song; John C Chambers; Weihua Zhang; Peter Vollenweider; Heide Stirnadel; Toby Johnson; Sven Bergmann; Noam D Beckmann; Yun Li; Luigi Ferrucci; David Melzer; Dena Hernandez; Andrew Singleton; James Scott; Paul Elliott; Gerard Waeber; Lon Cardon; Timothy M Frayling; Jaspal S Kooner; Vincent Mooser
Journal:  Am J Hum Genet       Date:  2008-10       Impact factor: 11.025
View more
  13 in total

Review 1.  Epidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic Origin.

Authors:  Mariana Lazo; Usama Bilal; Rafael Perez-Escamilla
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

Review 2.  Chemical modulation of glycerolipid signaling and metabolic pathways.

Authors:  Sarah A Scott; Thomas P Mathews; Pavlina T Ivanova; Craig W Lindsley; H Alex Brown
Journal:  Biochim Biophys Acta       Date:  2014-01-15

3.  Gut microbiota, fatty liver disease, and hepatocellular carcinoma.

Authors:  Huikuan Chu; Brandon Williams; Bernd Schnabl
Journal:  Liver Res       Date:  2018-02-21

4.  Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.

Authors:  Nicola Santoro; Clarence K Zhang; Hongyu Zhao; Andrew J Pakstis; Grace Kim; Romy Kursawe; Daniel J Dykas; Allen E Bale; Cosimo Giannini; Bridget Pierpont; Melissa M Shaw; Leif Groop; Sonia Caprio
Journal:  Hepatology       Date:  2011-12-18       Impact factor: 17.425

Review 5.  Animal models of nonalcoholic fatty liver disease.

Authors:  Lionel Hebbard; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-30       Impact factor: 46.802

6.  Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2.

Authors:  François R Jornayvaz; Andreas L Birkenfeld; Michael J Jurczak; Shoichi Kanda; Blas A Guigni; Debbie C Jiang; Dongyan Zhang; Hui-Young Lee; Varman T Samuel; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

7.  Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice.

Authors:  Nathan A Ungerleider; Lara M Bonomi; Melissa L Brown; Alan L Schneyer
Journal:  Endocrinology       Date:  2013-03-26       Impact factor: 4.736

8.  Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis.

Authors:  Stuart Astbury; Edmond Atallah; Amrita Vijay; Guruprasad P Aithal; Jane I Grove; Ana M Valdes
Journal:  Gut Microbes       Date:  2019-11-07

9.  Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant.

Authors:  Colin N A Palmer; Cristina Maglio; Carlo Pirazzi; Maria Antonella Burza; Martin Adiels; Lindsay Burch; Louise A Donnelly; Helen Colhoun; Alexander S Doney; John F Dillon; Ewan R Pearson; Mark McCarthy; Andrew T Hattersley; Tim Frayling; Andrew D Morris; Markku Peltonen; Per-Arne Svensson; Peter Jacobson; Jan Borén; Lars Sjöström; Lena M S Carlsson; Stefano Romeo
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

10.  The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.

Authors:  Hans Dieter Nischalke; Cordula Berger; Carolin Luda; Thomas Berg; Tobias Müller; Frank Grünhage; Frank Lammert; Martin Coenen; Benjamin Krämer; Christian Körner; Natascha Vidovic; Johannes Oldenburg; Jacob Nattermann; Tilman Sauerbruch; Ulrich Spengler
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.